Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Inhibition Of Protein Kinase C By The 12-O-tetradecanoylphorbol-13-acetate Antagonist Glycyrrhetic Acid.

C. O'brian, N. Ward, V. Vogel
Published 1990 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Glycyrrhetic acid is an anti-inflammatory agent isolated from licorice root that inhibits 12-O-tetradecanoylphorbol-13-acetate (TPA)-mediated tumor promotion in mouse skin. Although it has been established that glycyrrhetic acid inhibits a number of events induced by the phorbol ester tumor promoter TPA in cultured cells, its mechanisms of action has remained obscure. In this report, we demonstrate that glycyrrhetic acid inhibits the Ca2+-and phospholipid-dependent phosphotransferase activity of protein kinase C (PKC), the phorbol ester tumor promoter receptor. Therefore, inhibition of PKC may play a role in the anti-promoting activity of glycyrrhetic acid.
This paper references
10.1126/SCIENCE.3014651
Studies and perspectives of protein kinase C.
Y. Nishizuka (1986)
10.1093/JNCI/80.20.1628
Role of specific interactions between protein kinase C and triphenylethylenes in inhibition of the enzyme.
C. O'brian (1988)
10.20772/CANCERSCI1985.77.1_33
Glycyrrhetic acid inhibits tumor-promoting activity of teleocidin and 12-O-tetradecanoylphorbol-13-acetate in two-stage mouse skin carcinogenesis.
H. Nishino (1986)
10.1016/0304-3835(84)90131-9
Inhibition of 12-O-tetradecanoylphorbol-13-acetate-stimulated 3-O-methyl-glucose transport in mouse Swiss 3T3 fibroblasts by glycyrrhetic acid.
K. Kitagawa (1984)
The origins of human cancer: molecular mechanisms of carcinogenesis and their implications for cancer prevention and treatment--twenty-seventh G.H.A. Clowes memorial award lecture.
I. Weinstein (1988)
10.1093/CARCIN/9.8.1451
The bile acid analog fusidic acid can replace phosphatidylserine in the activation of protein kinase C by 12-O-tetradecanoylphorbol-13-acetate in vitro.
N. Ward (1988)
10.1093/JNCI/56.2.441
Promoting effect of sodium deoxycholate on colon adenocarcinomas in germfree rats.
B. Reddy (1976)
10.1093/CARCIN/5.11.1529
Antitumor-promoting activity of glycyrrhetic acid in mouse skin tumor formation induced by 7,12-dimethylbenz[a]anthracene plus teleocidin.
H. Nishino (1984)
10.1159/000226348
Inhibition of the specific binding of 12-O-tetradecanoylphorbol-13-acetate to mouse epidermal membrane fractions by glycyrrhetic acid.
K. Kitagawa (1986)
Effects of antiinflammatory agents on mouse skin tumor promotion, epidermal DNA synthesis, phorbol ester-induced cellular proliferation, and production of plasminogen activator.
A. Viaje (1977)
10.1093/CARCIN/8.2.217
The regulation of protein kinase C by chenodeoxycholate, deoxycholate and several structurally related bile acids.
C. Fitzer (1987)
10.1016/0006-291X(84)90951-3
Protein kinase C phosphorylates the synthetic peptide Arg-Arg-Lys-Ala-Ser-Gly-Pro-Pro-Val in the presence of phospholipid plus either Ca2+ or a phorbol ester tumor promoter.
C. O'brian (1984)
10.1093/JNCI/53.4.1093
Promoting effect of bile acids on colon carcinogenesis after intrarectal instillation of N-methyl-N'-nitro-N-nitrosoguanidine in rats.
T. Narisawa (1974)
10.1016/0304-3835(83)90079-4
Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced ornithine decarboxylase activity in mouse epidermis by sweetening agents and related compounds.
H. Okamoto (1983)
10.1111/j.1365-2265.1983.tb00038.x
AFFINITY OF LIQUORICE DERIVATIVES FOR MINERALOCORTICOID AND GLUCOCORTICOID RECEPTORS
D. Armanini (1983)



This paper is referenced by
10.1016/J.AJPS.2013.07.009
Application of cationic liposomes for delivery of nucleic acids
G. Shim (2013)
10.1007/978-94-017-7276-1_18
Glycyrrhiza glabra
T. K. Lim (2015)
10.1016/j.ijpharm.2010.06.029
Development of glycyrrhetinic acid-modified stealth cationic liposomes for gene delivery.
Z. He (2010)
10.1080/13880200600686491
Cancer Preventive Agents. Part 5. Anti-tumor-Promoting Effects of Coumarins and Related Compounds on Epstein-Barr Virus Activation and Two-stage Mouse Skin Carcinogenesis
M. Suzuki (2006)
10.1039/c5bm00224a
Glycyrrhetinic acid-decorated and reduction-sensitive micelles to enhance the bioavailability and anti-hepatocellular carcinoma efficacy of tanshinone IIA.
F. Chen (2016)
10.1016/j.bmcl.2012.04.049
Utilization of [11C]phosgene for radiosynthesis of N-(2-{3-[3,5-bis(trifluoromethyl)]phenyl[11C]ureido}ethyl)glycyrrhetinamide, an inhibitory agent for proteasome and kinase in tumors.
Chiharu Asakawa (2012)
10.1007/S10330-003-0198-4
18β-glycyrrhetinic Acid-induced Apoptosis and Relation with Intracellular Ca2+ Release in Human Breast Carcinoma Cells
Luo Hui-ling (2004)
Virus discovery and human coronavirus NL63
K. Pyrć (2007)
10.1007/s10856-011-4494-1
Design and synthesis of dual-ligand modified chitosan as a liver targeting vector
Houxiang Chen (2011)
10.1016/j.ejphar.2009.09.046
Glycyrrhizin and its metabolite 18 beta-glycyrrhetinic acid in glycyrrhiza, a constituent herb of yokukansan, ameliorate thiamine deficiency-induced dysfunction of glutamate transport in cultured rat cortical astrocytes.
Z. Kawakami (2010)
10.1016/S0024-3205(01)01556-9
Differential regulation of activator protein 1 activity by glycyrrhizin.
C. Hsiang (2002)
10.1039/C8PY00344K
Mechanisms of TPGS and its derivatives inhibiting P-glycoprotein efflux pump and application for reversing multidrug resistance in hepatocellular carcinoma
Tengfei Liu (2018)
10.1016/j.antiviral.2005.03.002
Development of antiviral therapy for severe acute respiratory syndrome
J. Cinatl (2005)
10.1007/BF02510095
Pharmacological and therapeutic properties of licorice preparations (A review)
G. V. Obolentseva (2006)
10.1016/j.neuroscience.2009.02.004
Neuroprotective effects of yokukansan, a traditional japanese medicine, on glutamate-mediated excitotoxicity in cultured cells
Z. Kawakami (2009)
10.1016/S1569-2558(08)60235-0
Altered Signal Transduction in Carcinogenesis1
C. O'brian (1993)
10.1016/j.cellbi.2008.08.007
Effects of 18‐glycyrrhetinic acid on serine 368 phosphorylation of connexin43 in rat neonatal cardiomyocytes
Jyun-Yan Liang (2008)
10.1079/NRR19940011
Anticarcinogenic factors in plant foods: a new class of nutrients?
I. Johnson (1994)
10.1080/10915810701351228
Final report on the safety assessment of Glycyrrhetinic Acid, Potassium Glycyrrhetinate, Disodium Succinoyl Glycyrrhetinate, Glyceryl Glycyrrhetinate, Glycyrrhetinyl Stearate, Stearyl Glycyrrhetinate, Glycyrrhizic Acid, Ammonium Glycyrrhizate, Dipotassium Glycyrrhizate, Disodium Glycyrrhizate, Triso
Succinoyl (2007)
10.1080/10717544.2018.1526227
Antitumor activities of novel glycyrrhetinic acid-modified curcumin-loaded cationic liposomes in vitro and in H22 tumor-bearing mice
Mingxiang Chang (2018)
10.1016/j.carbpol.2020.116781
Chitosan based pH-responsive polymeric prodrug vector for enhanced tumor targeted co-delivery of doxorubicin and siRNA.
Tingsheng Yan (2020)
10.1016/S1572-5995(00)80024-1
Natural Triterpenoids as Anti-Inflammatory Agents
J. Rios (2000)
10.1016/S0014-2999(00)00860-8
Effect of triterpenoids on the inflammation induced by protein kinase C activators, neuronally acting irritants and other agents.
A. Huguet (2000)
10.1016/S1572-5995(01)80005-3
Antitumor-promoting and anti-inflammatory activities of triterpenoids and sterols from plants and fungi
T. Akihisa (2001)
10.3390/vaccines8020335
SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug Discoveries
Hatem A Elshabrawy (2020)
10.1088/1361-6528/ab8c03
Glycyrrhetinic acid modified MOFs for the treatment of liver cancer.
Li Li (2020)
10.3746/JFN.2003.8.1.029
Characterization of the Immunologically Active Components of Glycyrrhiza uralensis Prepared as Herbal Kimchi
Jong-hyun Hwang (2003)
10.1016/j.ejphar.2011.08.043
Glycyrrhetinic acid prevents cutaneous scratching behavior in mice elicited by substance P or PAR-2 agonist.
Y. Akasaka (2011)
10.1002/CPHY.CP080232
Corticosteroids and the kidney.
D. Marver (1990)
10.1207/S15327914nc391_1
Licorice and Cancer
Z. Wang (2001)
10.11642/KYUSHUNEUROP.58.3_4_133
The Efficacy of Yokukansan to Treat the Behavioral and Psychological Symptoms of Dementia Patients
Y. Hayashi (2012)
Semantic Scholar Logo Some data provided by SemanticScholar